SpectraWave Blood Donor Solutions addresses the analysis needs of the global blood products market, from collection through delivery of blood-based therapeutic products to a customer. Safety of the blood supply and products, including whole blood transfusions, platelets and specialty antibodies to fight disease is a global priority. In mobile donor centers, remote areas and on the field of battle, the ability to accurately assess donor health and safety and assure product safety, potency and compatibility before transfusion is critical to successful patient outcomes and minimizing adverse events. SpectraWave Blood Donor Solutions can provide comprehensive information in real time, including blood typing, quantification and titer levels and screening for contaminants and aggregates. The same technology can also be used to monitor the quality of blood and blood products that are stored for future use. This product application leverages the investment being made in advancing SpectraWave Hematology Solutions. This is a niche opportunity, both in terms of product specifications and customers. As such, it will not compete with hospital, clinic or healthcare-driven use of Hematology Solutions. It also creates an opportunity to receive revenues from a partner for product development and clinical studies integral to advancing Claro’s own medical diagnostic commercial application.